Kareem Ebeid
Impact in
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
- Cancer therapeutics and mechanisms 2
- Oncology 5
- Cancer-related Molecular Pathways 2
- Co-authors
- Aliasger K. Salem (17 shared papers)Sean M. Geary (6 shared papers)Emad I. Wafa (6 shared papers)Youssef W. Naguib (7 shared papers)Angie S. Morris (2 shared papers)Xiangbing Meng (3 shared papers)Amaraporn Wongrakpanich (2 shared papers)Aml I. Mekkawy (3 shared papers)
- Journals
- Bioconjugate Chemistry (2 papers)Biomaterials (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)Molecular Pharmaceutics (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United StatesEgyptThailand
In The Last Decade
Kareem Ebeid
19 papers receiving 344 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 74
- Pharmaceutical Science 20
- Toxicology 9
- Molecular Biology 165
- Immunology 43
Countries citing papers authored by Kareem Ebeid
This map shows the geographic impact of Kareem Ebeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kareem Ebeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kareem Ebeid more than expected).
Fields of papers citing papers by Kareem Ebeid
This network shows the impact of papers produced by Kareem Ebeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kareem Ebeid. The network helps show where Kareem Ebeid may publish in the future.
Co-authors
The 25 scholars most cited alongside Kareem Ebeid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 63 | |
| 2 | 2015 | 44 | |
| 3 | 2022 | 41 | |
| 4 | 2022 | 27 | |
| 5 | 2022 | 24 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2017 | 18 | |
| 9 | 2019 | 17 | |
| 10 | 2021 | 12 | |
| 11 | 2023 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 3 | |
| 18 | 2016 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2022 | 0 |
About Kareem Ebeid
Kareem Ebeid is a scholar working on Molecular Biology, Oncology, Immunology, Biomaterials and Cell Biology, having authored 21 papers that have together received 347 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Nanoplatforms for cancer theranostics (3 papers), Immunotherapy and Immune Responses (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and biological activity (2 papers), Cellular Mechanics and Interactions (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Biomaterials (74 citations), Pharmaceutical Science (20 citations), Toxicology (9 citations), Molecular Biology (165 citations) and Immunology (43 citations). Kareem Ebeid has collaborated with scholars based in United States, Egypt and Thailand. Frequent co-authors include Aliasger K. Salem, Sean M. Geary, Emad I. Wafa, Youssef W. Naguib, Angie S. Morris, Xiangbing Meng, Amaraporn Wongrakpanich, Aml I. Mekkawy, Kristina W. Thiel and Kimberly K. Leslie. Their work appears in journals such as Bioconjugate Chemistry, Biomaterials, Journal of Enzyme Inhibition and Medicinal Chemistry, Molecular Pharmaceutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.